Atlas Trials

Anakinra for the Treatment of Chronically Inflamed White Matter Lesions in Multiple Sclerosis

Clinical trial NCT04025554 · COMPLETED

Trial details

NCT number
NCT04025554
Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2019-10-25
Primary completion
2023-10-24
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.